Company attributes
Industry
B2X
0
Founder
AngelList URL
Pitchbook URL
Date Incorporated
2002
Number of Employees (Ranges)
51 – 2000
CIK Number
Place of Incorporation
Investors
DUNS Number
1965019310
IRS Number
651,178,8220
Founded Date
2002
Total Funding Amount (USD)
76,000,000
Latest Funding Type
CAGE Code
64WX30
Patents Assigned (Count)
16
Wellfound ID
Country
Other attributes
Acquirer
Company Operating Status
Active
SIC Code
2,8340
Wikidata ID
Orexigen Therapeutics is a biopharmaceutical company developing treatments for obesity that is headquartered in La Jolla, California and was founded in 2002 by Eckard Weber.
Acquired by Nalpropion Pharmaceuticals
On April 23, 2018 Orexigen Therapeutics entered into an asset purchase agreement with Nalpropion Pharmaceuticals for $75 million. The agreement gave Nalpriopion Pharmaceuticals rights to several therapeutic products and other assets held by Orexigen Therapeutics.
Timeline
No Timeline data yet.
